| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.316 | 18.992 | 21.255 | 24.295 | 29.685 | 24.344 | 20.352 | 14.964 | 0 | 0 |
| Total Income - EUR | 26.329 | 21.392 | 27.229 | 29.653 | 29.686 | 25.763 | 26.549 | 322.538 | 1.750 | 0 |
| Total Expenses - EUR | 14.625 | 14.708 | 15.323 | 19.835 | 17.514 | 13.301 | 17.196 | 17.629 | 13.245 | 12.892 |
| Gross Profit/Loss - EUR | 11.704 | 6.684 | 11.906 | 9.818 | 12.172 | 12.462 | 9.353 | 304.909 | -11.495 | -12.892 |
| Net Profit/Loss - EUR | 10.911 | 6.041 | 11.089 | 8.928 | 11.281 | 11.753 | 8.556 | 296.376 | -11.495 | -12.896 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Pharmakon Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 149.503 | 152.447 | 145.762 | 141.133 | 133.608 | 126.374 | 117.418 | 114.723 | 111.488 | 109.300 |
| Current Assets | 224.326 | 223.408 | 215.342 | 222.170 | 202.817 | 204.740 | 55.571 | 350.287 | 342.240 | 328.891 |
| Inventories | 189.267 | 187.336 | 184.166 | 180.787 | 177.285 | 173.924 | 32.605 | 32.706 | 32.607 | 32.425 |
| Receivables | 17.613 | 18.906 | 15.701 | 15.370 | 15.067 | 18.657 | 14.668 | 15.830 | 15.904 | 15.904 |
| Cash | 17.446 | 17.165 | 15.474 | 26.014 | 10.464 | 12.159 | 8.298 | 301.750 | 293.729 | 280.563 |
| Shareholders Funds | 84.389 | 89.569 | 99.143 | 106.252 | 115.475 | 125.094 | 130.876 | 427.658 | 414.865 | 117.256 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 287.643 | 284.507 | 261.182 | 256.286 | 220.199 | 205.284 | 42.113 | 37.352 | 38.862 | 320.936 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Pharmakon Srl